Health Enhancement Products Announces Expansion of Its Primary Facility

Plans to Double the Size of Its Current Grow Room, Thereby Doubling the Amount of Product That Can be Produced On a Monthly Basis


SCOTTSDALE, Ariz., July 1, 2009 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI) announced today that they have received a commitment for financing that will enable them to once again double the amount of product that can be produced on a monthly basis. The financing comes from a core group of investors who have supported the company over the last 12 months.

HEPI's current facility can produce approximately 38,000 32oz bottles per month. Once the new build out is complete, the Company anticipates that they will be able to produce approximately 76,000 bottles per month. The build out had been started a year ago, but due to a lack of funds and a low demand for the product, the build out had been discontinued. The company has determined that, based on current and anticipated activities, the additional growing area will be necessary.

About Health Enhancement Products, Inc. and ProAlgaZyme: Health Enhancement Products Inc. is a nutraceutical company engaged in the development of a Dietary Supplement product using only pure, all-natural ingredients. The company's sole product is ProAlgaZyme, a liquid product produced from algae grown in 100% pure water. The liquid in which the algae are grown is drawn off, filtered, tested and bottled as ProAlgaZyme.

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

For more information, please visit www.heponline.com.



            

Contact Data